Genous CoCr

EPC Capturing Technology

Endothelial Progenitor Cells (EPCs) play a crucial role in vascular repair and endothelialization.

EPCs were first described by Asahara in 1996 as circulating CD34+ cells with the potential to differentiate into endothelial cells
EPCs are bone marrow-derived cells that are mobilized in response to tissue or vessel injury and incorporate into the sites of injury
EPC capture is central to our healing technology
Endothelial coverage is a histological predictor of stent thrombosis after stent placement

How does Genous facilitate EPC capture and endothelialization?

Design and Materials

The Genous CoCr stent has a unique dual helix design that provides natural conformability and tremendous radial strength without compromising its extreme flexibility.

Squared Ends

– for lesion coverage and minimal foreshortening

Dual Helix Backbone

– for flexibility, radial strength and natural conformability

Clinical Program

At OrbusNeich, we remain relentless in our commitment to improving the long-term quality of life for patients.

Driven by our mission to be global leaders in life-changing vascular technologies, we work together with our physician partners to understand and meet clinical needs.